IMMUNITYBIO, INC.

Transcripts ImmunityBio, Inc.

Equities

IBRX

US45256X1037

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
7.35 ^USD	+43.84%		+39.47%	+46.41%

Apr. 26	Transcript : ImmunityBio, Inc. - Special Call
Apr. 25	ImmunityBio, Inc. Announces Positive Overall Survival Results of Anktiva Combined with Checkpoint Inhibitors in Non-Small Cell Lung Cancer	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : ImmunityBio, Inc. - Special Call	Apr. 26
Transcript : ImmunityBio, Inc. - Special Call	23-09-21
Transcript : NantKwest, Inc. Presents at 39th Annual JPMorgan Virtual Healthcare Conference, Jan-13-2021 05:20 AM	21-01-13
Transcript : ImmunityBio, Inc., NantKwest, Inc. - M&A Call	20-12-21
Transcript : NantKwest, Inc. - Special Call	20-05-27
Transcript : NantKwest, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-14-2020 11:00 AM	20-01-14
Transcript : NantKwest, Inc. - Special Call	19-12-02
Transcript : NantKwest, Inc. - Analyst/Investor Day	19-01-08
Transcript : NantKwest, Inc. - Analyst/Investor Day	18-01-09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer